Repurposing Food and Drug Administration-Approved Drugs to Promote Antitumor Immunity.

Sukhatme, Vidula V; Ramalingam, Suresh S; Ahmed, Rafi; Sukhatme, Vikas P

Sukhatme, Vidula V; Ramalingam, Suresh S; Ahmed, Rafi; Sukhatme, Vikas P.

Afiliación

Ramalingam SS; Department of Hematology and Medical Oncology and Winship Cancer Institute.
Ahmed R; Department of Microbiology and Immunology and Emory Vaccine Center, and.
Sukhatme VP; Center for Affordable Medical Innovation and Department of Medicine, Emory University School of Medicine, Atlanta, GA.

Cancer J ; 25(2): 88-99, 2019.

Article en En | MEDLINE | ID: mdl-30896530

Asunto(s)

Neoplasias/tratamiento farmacológico; Neoplasias/inmunología; Humanos; Estados Unidos; United States Food and Drug Administration

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Cancer J Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google